[ad_1]
October 27, 2020 9:27 PM
42
The picture shows President Jokowi inspecting the new crown vaccine production site in Bandung.
[Red de noticias independiente]The Ministry of Planning and National Construction (Kemristek) invited three private companies to cooperate to produce one billion doses of the Covid-19 vaccine each year.
“The government has invited three private companies to cooperate and will produce 1 billion doses of the Covid-19 vaccine every year.
This therefore means that Indonesia will become one of the vaccine producers in the future. ”Class of the Minister of National Construction PlanningBombrosone goro（Bambang Brodjonegoro) Said this in a video conference on the prevention and control of the new corona pneumonia epidemic in Yajing on Tuesday (October 27).
Banbang said the three private companies have already started to process the Manufacturing Practices License from the Food and Pharmaceutical Regulatory Agency (BPOM). However, Banbang did not specify the names of these three private companies.
However, under the coordination of PT Bio Farma, there are many private companies that have potential cooperation with the pharmaceutical industry are PT Kalbe Farma, PT Sanbe Farma, PT Daewoong Infion, PT Biotis Prima Agrisindo and PT Tempo Scan Pacific.
The role of private companies is critical in supporting the independence of vaccine production, especially red and white vaccines, to meet national vaccine needs. Banbang said he can guarantee that 100% of the red and white vaccines can be produced in the country, and that the new corona pneumonia vaccine will be needed not only this year but also in the years to come. “
Banbang said that the immune system generated by the first vaccine is likely not to last a lifetime, so a second vaccine is needed to prevent the outbreak of a new coronary pneumonia. Therefore, it must have the ability to produce a new corona vaccine.
Banbang continued: Vaccine production cannot depend solely on the capabilities of the state-owned company PT Bio Farma. Because Indonesia has a large population, a large number of vaccines are needed to meet the needs of 270 million people, especially if re-vaccination is necessary in the future.
To this end, PT Bio Farma has increased its vaccine production capacity to 250 million doses per year. Bio Farma also plans to form an alliance with national private companies to produce higher volumes of red and white vaccines. (ADR)
“The government has invited three private companies to cooperate and will produce 1 billion doses of the Covid-19 vaccine every year.
This therefore means that Indonesia will become one of the vaccine producers in the future. ”Class of the Minister of National Construction PlanningBombrosone goro（Bambang Brodjonegoro) Said this in a video conference on the prevention and control of the new corona pneumonia epidemic in Yajing on Tuesday (October 27).
Banbang said the three private companies have already started to process the Manufacturing Practices License from the Food and Pharmaceutical Regulatory Agency (BPOM). However, Banbang did not specify the names of these three private companies.
However, under the coordination of PT Bio Farma, there are many private companies that have potential cooperation with the pharmaceutical industry are PT Kalbe Farma, PT Sanbe Farma, PT Daewoong Infion, PT Biotis Prima Agrisindo and PT Tempo Scan Pacific.
The role of private companies is critical in supporting the independence of vaccine production, especially red and white vaccines, to meet national vaccine needs. Banbang said he can guarantee that 100% of the red and white vaccines can be produced in the country, and that the new corona pneumonia vaccine will be needed not only this year but also in the years to come. “
Banbang said that the immune system generated by the first vaccine is likely not to last a lifetime, so a second vaccine is needed to prevent the outbreak of a new coronary pneumonia. Therefore, it must have the ability to produce a new corona vaccine.
Banbang continued: Vaccine production cannot depend solely on the capabilities of the state-owned company PT Bio Farma. Because Indonesia has a large population, a large number of vaccines are needed to meet the needs of 270 million people, especially if re-vaccination is necessary in the future.
To this end, PT Bio Farma has increased its vaccine production capacity to 250 million doses per year. Bio Farma also plans to form an alliance with national private companies to produce higher volumes of red and white vaccines. (ADR)
[ad_2]
